Source link : https://newshealth.biz/health-news/another-practice-changing-study-in-high-risk-bladder-cancer/
(MedPage Today) — BERLIN — Adding durvalumab (Imfinzi) to bacillus Calmette-Guérin (BCG) induction and maintenance therapy significantly improved disease-free survival (DFS) in patients with BCG-naive, high-risk non-muscle-invasive bladder… Source link : https://www.medpagetoday.com/meetingcoverage/esmo/118010 Author : Publish date : 2025-10-17 20:54:00 Copyright for syndicated content belongs to the linked Source.
The post Another ‘Practice-Changing’ Study in High-Risk Bladder Cancer first appeared on News Health.
—-
Author : News Health
Publish date : 2025-10-17 20:54:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8